معرفی
Prof. Dr. Rawa Arif is a senior cardiovascular surgeon and research group leader at University Hospital Heidelberg, specializing in Marfan syndrome and aortic dissections. Holding dual roles as Deputy Medical Director and Managing Consultant in the Department of Cardiac Surgery, he also serves as Head of the Marfan Center and leads the Working Group on Multimodal Therapy of Marfan Syndrome. His clinical expertise spans heart transplantation, MIDCAB, TAVI, and endoscopic valve surgery.
- Habilitation (2020): 'Influence of endothelial dysfunction and structural vascular wall changes on outcomes of cardiac surgery patients'
- Medical education: University of Heidelberg, Erasmus exchange in Vienna, practical year at Heidelberg University Hospital and Bern University Hospital
Research focuses on genetic therapy for Marfan syndrome and transplant vasculopathy, with significant funding from the German Research Foundation (DFG) and Dietmar Hopp Foundation. Key publications address minimal-invasive Marfan therapy, transplant vasculopathy, and endothelial dysfunction mechanisms. Awards include the 2017 Gefäßchirurgischer Forschungspreis and 2021 Franz J. Köhler Preis. 2022-2024 research highlights include rapamycin treatment in Marfan models and AAV-based gene therapy approaches.
Teaching roles include Deputy Coordinator of New Heart Center Construction and Chair of Medical Faculty Promotion Committee. Collaborations span the German Registry for Acute Aortic Dissection Type A (GERAADA) and interdisciplinary teams at Heidelberg's cardiac facilities.
